Cargando…
Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens
BACKGROUND: To develop effective strategies in cancer chemoprevention, an increased understanding of endogenous biochemical mediators that block metastatic processes is critically needed. Dietary lipids and non-steroidal anti-inflammatory drugs (NSAIDs) have a published track record of providing pro...
Autores principales: | Wood, Paul L, Khan, M Amin, Smith, Tara, Goodenowe, Dayan B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231815/ https://www.ncbi.nlm.nih.gov/pubmed/22087745 http://dx.doi.org/10.1186/1476-511X-10-214 |
Ejemplares similares
-
Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction
por: Wood, Paul L, et al.
Publicado: (2011) -
In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor
por: Wood, Paul L, et al.
Publicado: (2011) -
Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study
por: Mankidy, Rishikesh, et al.
Publicado: (2010) -
Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease
por: Wood, Paul L, et al.
Publicado: (2011) -
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
por: Senanayake, Vijitha, et al.
Publicado: (2019)